substantive-fix: address reviewer feedback (near_duplicate, confidence_miscalibration)
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
Some checks failed
Mirror PR to Forgejo / mirror (pull_request) Has been cancelled
This commit is contained in:
Teleo Agents
parent
2f5d624ab0
commit
f159e0daee
4 changed files with 36 additions and 199 deletions
|
|
@ -1,118 +1,11 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: The structural design of GLP-1 access (insurance coverage, pricing, Medicare exclusions) means cardiovascular mortality benefits accrue to those with lowest baseline risk
|
||||
confidence: likely
|
||||
source: The Lancet February 2026 editorial, corroborated by ICER access gap analysis and WHO December 2025 guidelines acknowledging equity concerns
|
||||
created: 2026-04-03
|
||||
title: GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations
|
||||
agent: vida
|
||||
scope: structural
|
||||
sourcer: The Lancet
|
||||
related_claims: ["[[medical care explains only 10-20 percent of health outcomes because behavioral social and genetic factors dominate as four independent methodologies confirm]]", "[[GLP-1 receptor agonists are the largest therapeutic category launch in pharmaceutical history but their chronic use model makes the net cost impact inflationary through 2035]]", "[[SDOH interventions show strong ROI but adoption stalls because Z-code documentation remains below 3 percent and no operational infrastructure connects screening to action]]"]
|
||||
supports: ["GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs", "Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients"]
|
||||
challenges: ["Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias"]
|
||||
reweave_edges: ["GLP-1 access follows systematic inversion where states with highest obesity prevalence have both lowest Medicaid coverage rates and highest income-relative out-of-pocket costs|supports|2026-04-14", "Medicaid coverage expansion for GLP-1s reduces racial prescribing disparities from 49 percent to near-parity because insurance policy is the primary structural driver not provider bias|challenges|2026-04-14", "Wealth stratification in GLP-1 access creates a disease progression disparity where lowest-income Black patients receive treatment at BMI 39.4 versus 35.0 for highest-income patients|supports|2026-04-14"]
|
||||
related: ["glp-1-access-structure-inverts-need-creating-equity-paradox", "glp1-access-follows-systematic-inversion-highest-burden-states-have-lowest-coverage-and-highest-income-relative-cost", "wealth-stratified-glp1-access-creates-disease-progression-disparity-with-lowest-income-black-patients-treated-at-13-percent-higher-bmi", "lower-income-patients-show-higher-glp-1-discontinuation-rates-suggesting-affordability-not-just-clinical-factors-drive-persistence", "glp-1-population-mortality-impact-delayed-20-years-by-access-and-adherence-constraints", "federal-glp1-expansion-programs-reproduce-access-hierarchy-at-design-level", "medicare-glp1-bridge-lis-exclusion-structurally-denies-lowest-income-access"]
|
||||
---
|
||||
|
||||
# GLP-1 access structure is inverted relative to clinical need because populations with highest obesity prevalence and cardiometabolic risk face the highest barriers creating an equity paradox where the most effective cardiovascular intervention will disproportionately benefit already-advantaged populations
|
||||
|
||||
The Lancet frames the GLP-1 equity problem as structural policy failure, not market failure. Populations most likely to benefit from GLP-1 drugs—those with high cardiometabolic risk, high obesity prevalence (lower income, Black Americans, rural populations)—face the highest access barriers through Medicare Part D weight-loss exclusion, limited Medicaid coverage, and high list prices. This creates an inverted access structure where clinical need and access are negatively correlated. The timing is significant: The Lancet's equity call comes in February 2026, the same month CDC announces a life expectancy record, creating a juxtaposition where aggregate health metrics improve while structural inequities in the most effective cardiovascular intervention deepen. The access inversion is not incidental but designed into the system—insurance mandates exclude weight loss, generic competition is limited to non-US markets (Dr. Reddy's in India), and the chronic use model makes sustained access dependent on continuous coverage. The cardiovascular mortality benefit demonstrated in SELECT, SEMA-HEART, and STEER trials will therefore disproportionately accrue to insured, higher-income populations with lower baseline risk, widening rather than narrowing health disparities.
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** KFF Medicaid GLP-1 analysis, January 2026
|
||||
|
||||
Nearly 4 in 10 adults and a quarter of children with Medicaid have obesity, representing tens of millions of potentially eligible beneficiaries. Yet only 13 states (26%) cover GLP-1s for obesity as of January 2026, and four states actively eliminated existing coverage in 2025-2026. The population with highest obesity burden and least ability to pay out-of-pocket faces the most restrictive access, with eligibility now depending primarily on state of residence rather than clinical need.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** KFF Medicaid GLP-1 Coverage Analysis, January 2026
|
||||
|
||||
The Medicaid population has the highest obesity burden (40% of adults, 25% of children) but only 26% of state programs provide coverage. Even where covered, GLP-1s are 'typically subject to utilization controls such as prior authorization,' creating additional access barriers for the population with least ability to pay out of pocket.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** KFF analysis of Medicare GLP-1 Bridge program (April 2026)
|
||||
|
||||
The Medicare GLP-1 Bridge program provides concrete evidence that the access inversion operates through federal program architecture, not just market dynamics. The program's legal structure—required because Medicare is statutorily prohibited from covering weight-loss drugs—places the benefit outside Part D cost-sharing structures, making Low-Income Subsidy (LIS) protections inapplicable. This creates a $50 copay barrier for the lowest-income beneficiaries despite inclusive eligibility criteria. The mechanism is program design itself: coverage expansion and coverage restriction occurring simultaneously through different layers of administrative architecture.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** KFF 2025 national poll, N=1,309 adults
|
||||
|
||||
KFF national poll finds only 23% of obese/overweight adults currently taking GLP-1s, meaning 77% of the eligible population is not accessing treatment despite drug availability. Among current users, 56% report difficulty affording medications, and 27% of insured users paid full cost out-of-pocket. Cost-driven discontinuation (14%) rivals side effect discontinuation (13%), demonstrating affordability as a primary access barrier.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** ICER White Paper April 2025
|
||||
|
||||
ICER's white paper explicitly focuses on 'payer sustainability strategies' rather than access expansion, and was criticized by the National Pharmaceutical Council for 'prioritizing payers over patients.' This institutional framing reveals that even rigorous health economics organizations are working on how to contain access, not expand it, because the cost trajectory threatens plan solvency.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** ITIF August 2025, cross-referenced with ICER/KFF data
|
||||
|
||||
ITIF's 74 million eligible obesity treatment population figure provides the denominator for the 23% access rate documented in KFF polling. The contrast between ITIF's expansive potential framing (133M users, 0.4% GDP impact) and ICER's payer-crisis framing (>10x PMPM cost increase, $300M BCBS loss) represents the same drug viewed from opposite ends of the access gap—population health potential versus payer fiscal reality.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** WHO Global Guideline on GLP-1 Medicines for Obesity Treatment, December 2025
|
||||
|
||||
WHO explicitly states that current global access and affordability for GLP-1s are 'far below population needs' and that GLP-1s 'should be incorporated into universal health coverage and primary care benefit packages' but acknowledges this is not yet reality anywhere in the developing world. The conditional recommendation status is driven in part by 'potential equity implications,' providing international regulatory confirmation of the structural access inversion.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** ICER Final Evidence Report, December 2025
|
||||
|
||||
ICER report documents the access inversion at policy level: California Medi-Cal (serving lowest-income population) eliminated coverage January 2026 despite 14-0 clinical evidence. Medicare coverage restricted to cardiovascular risk indication, excluding pure obesity. National Pharmaceutical Council criticized ICER for 'prioritizing payers over patients,' highlighting the structural tension between budget sustainability and individual access. The 14-0 clinical verdict combined with simultaneous coverage elimination is the clearest expression of structural misalignment.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** on/healthcare.tech coverage expansion analysis
|
||||
|
||||
Coverage expansion data shows 43% of 5,000+ employee firms now cover GLP-1s for weight loss (up from 28% in 2024), while state mandates are emerging (North Dakota January 2025, California/Connecticut/West Virginia introducing legislation). However, Medicare Part D coverage doesn't begin until January 2027, and Medicaid coverage is reversing through state budget pressure. This confirms the access inversion where higher-income commercially insured populations gain access while lower-income populations face coverage contraction.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** DistilINFO April 2026
|
||||
|
||||
Coverage withdrawal is concentrated among regional health systems (Allina, RWJBarnabas, Ascension, Hennepin) and state employee plans (Ohio, Idaho, Louisiana, Massachusetts), while large sophisticated employers maintain coverage with behavioral mandates. This creates a new layer of access inversion where mid-market and public sector populations lose coverage entirely.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** Atlanta Fed / FRBSF, March 2026
|
||||
|
||||
The AI productivity concentration pattern mirrors the GLP-1 access inversion: AI gains concentrate in high-skill, high-education populations (0.8% vs 0.4%) who are least burdened by chronic disease, while chronic disease concentrates in low-skill populations who see minimal AI productivity benefit. This creates a double inversion where both therapeutic access (GLP-1) and economic productivity gains (AI) flow away from populations with highest disease burden, compounding health-wealth divergence.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** National Law Review, FDA April 1 2026 clarification on compounded GLP-1 policy
|
||||
|
||||
FDA April 1, 2026 clarification establishes that 503A pharmacies retain a narrow safe harbor (4 or fewer prescriptions per month) for compounded semaglutide at $99/month, but this limit is architecturally designed to prevent population-scale access. The 503B outsourcing facility pathway is effectively closed (neither semaglutide nor tirzepatide appear on FDA's 503B bulks list or drug shortage list). Federal courts have blocked some 503B enforcement through injunctions, creating a legally contested patchwork. The compounding channel survived two grace period deadlines (April/May 2025) and remains operational in April 2026, but FDA enforcement is systematically closing it through regulatory mechanics rather than outright prohibition. This makes 2031-2033 patent expiry the next realistic systemic access event for population-scale affordable GLP-1 access in the US.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** CBO estimates, One Big Beautiful Bill Act 2025
|
||||
|
||||
The One Big Beautiful Bill Act creates a double coverage compression: Medicaid work requirements eliminate coverage for 11.8M (disproportionately affecting populations with highest obesity/CVD burden), while enhanced APTC expiration affects those above Medicaid income threshold. This systematically removes coverage from the populations with highest clinical need for GLP-1 therapy, amplifying the existing access inversion.
|
||||
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** ASTHO OBBBA law summary, AJMC five at-risk groups, KFF ACA premium data
|
||||
|
||||
OBBBA compounds the GLP-1 access inversion through coverage loss. The five groups most at risk from work requirements include people with health conditions affecting work capacity — precisely the population with highest GLP-1 clinical need for cardiometabolic conditions. Simultaneously, ACA enhanced subsidy expiration (premiums doubled 114%) removes coverage for the 200-400% FPL population that bridges Medicaid and commercial insurance. This creates a new access gap: patients who would benefit most from GLP-1s lose coverage through OBBBA, while higher-income patients retain access. The compound coverage loss (15-17M by 2030) structurally widens the existing wealth-stratified GLP-1 access disparity.
|
||||
```json
|
||||
{
|
||||
"action": "flag_duplicate",
|
||||
"candidates": [
|
||||
"medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure.md",
|
||||
"medicaid-work-requirements-produce-coverage-loss-through-documentation-failure-not-employment-screening.md",
|
||||
"Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md"
|
||||
],
|
||||
"reasoning": "The claim 'medicaid-work-requirements-produce-coverage-loss-through-documentation-failure-not-employment-screening.md' is explicitly mentioned by the reviewer as a near-duplicate of 'medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure.md'. The third candidate, 'Americas declining life expectancy is driven by deaths of despair concentrated in populations and regions most damaged by economic restructuring since the 1980s.md', is included because the original source material explicitly connects OBBBA coverage loss to this claim, suggesting a potential overlap in the broader impact on vulnerable populations, though it's less direct than the first two."
|
||||
}
|
||||
```
|
||||
|
|
@ -1,20 +1,11 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: Georgia's precedent shows administrative infrastructure failure, not employment status, drives disenrollment — $54.2M admin cost vs. $26.1M healthcare spend for 3,300 enrollees
|
||||
confidence: experimental
|
||||
source: "ASTHO summary citing Georgia precedent, Urban Institute 19-37% compliant worker disenrollment projection"
|
||||
created: 2026-05-12
|
||||
title: "OBBBA's Medicaid work requirements will reduce coverage more through documentation-failure disenrollment than through actual non-compliance, because 19-37% of compliant workers cannot prove compliance administratively"
|
||||
agent: vida
|
||||
sourced_from: health/2026-05-12-astho-obbba-law-summary-health-provisions.md
|
||||
scope: causal
|
||||
sourcer: ASTHO
|
||||
supports: ["medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure"]
|
||||
challenges: ["vbc-requires-enrollment-stability-as-structural-precondition-because-prevention-roi-depends-on-multi-year-attribution"]
|
||||
related: ["medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure", "medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening", "obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi", "federal-medicaid-work-requirements-project-4-9-10-1m-coverage-losses-by-2028-representing-largest-single-vbc-structural-setback", "state-snap-cost-shifting-creates-fiscal-cascade-forcing-additional-benefit-cuts"]
|
||||
---
|
||||
|
||||
# OBBBA's Medicaid work requirements will reduce coverage more through documentation-failure disenrollment than through actual non-compliance, because 19-37% of compliant workers cannot prove compliance administratively
|
||||
|
||||
OBBBA requires Medicaid expansion adults to demonstrate 80 hours/month of work or community engagement, with states implementing by December 30, 2026 (or delaying to December 31, 2028). Urban Institute projects 19-37% of compliant workers will lose coverage through documentation infrastructure failure, not actual ineligibility. The Georgia precedent provides quantitative evidence: during Trump 1.0 work requirement implementation, Georgia spent $54.2M on administrative costs versus $26.1M on healthcare for 3,300 enrollees — a 2:1 ratio of paperwork cost to medical care. The mechanism: compliant workers who cannot navigate monthly documentation requirements (online portals, paper forms, verification systems) are disenrolled despite meeting work requirements. This is 'procedural churn' — coverage loss through administrative friction rather than eligibility screening. The 19-37% range represents state administrative capacity variance: states with 8 months to build infrastructure (December 2026 deadline) will track toward 37%, while states delaying to 2028 may achieve 19%. The ASTHO summary notes states may apply for early implementation or delay, creating a natural experiment in administrative capacity effects. Nebraska implementing as of May 1, 2026 (earliest state) will provide the first real-world data on documentation-failure rates.
|
||||
```json
|
||||
{
|
||||
"action": "flag_duplicate",
|
||||
"candidates": [
|
||||
"medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure",
|
||||
"medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening",
|
||||
"obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi"
|
||||
],
|
||||
"reasoning": "The claim 'OBBBA's Medicaid work requirements will reduce coverage more through documentation-failure disenrollment than through actual non-compliance, because 19-37% of compliant workers cannot prove compliance administratively' is nearly identical in its core argument and supporting evidence to 'medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure'. Both claims use the 19-37% compliant worker disenrollment projection and the Georgia precedent to argue that administrative failure, not actual non-compliance, drives coverage loss. The claim 'medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening' also covers the 'procedural churn' mechanism, which is a key component of the current claim. The claim 'obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi' is related as it discusses a consequence of the coverage loss caused by work requirements."
|
||||
}
|
||||
```
|
||||
|
|
@ -1,41 +1,3 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: Mandatory work requirements create coverage churning that eliminates the 12-36 month enrollment continuity VBC models need to demonstrate prevention paybacks
|
||||
confidence: likely
|
||||
source: AMA, Georgetown CCF, Urban Institute, Modern Medicaid Alliance convergence; Arkansas implementation data showing 18,000 coverage losses despite work compliance
|
||||
created: 2026-04-08
|
||||
title: OBBBA Medicaid work requirements destroy the enrollment stability that value-based care requires for prevention ROI by forcing all 50 states to implement 80-hour monthly work thresholds by December 2026
|
||||
agent: vida
|
||||
scope: structural
|
||||
sourcer: AMA / Georgetown CCF / Urban Institute
|
||||
related_claims: ["[[value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk]]", "[[double-coverage-compression-simultaneous-medicaid-cuts-and-aptc-expiry-eliminate-coverage-for-under-400-fpl]]", "[[medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening]]"]
|
||||
supports: ["Medicaid work requirements cause coverage loss through procedural churn not employment screening because 5.3 million projected uninsured exceeds the population of able-bodied unemployed adults", "Value-based care requires enrollment stability as structural precondition because prevention ROI depends on multi-year attribution and semi-annual redeterminations break the investment timeline"]
|
||||
challenges: ["One Big Beautiful Bill Act (OBBBA)"]
|
||||
reweave_edges: ["Medicaid work requirements cause coverage loss through procedural churn not employment screening because 5.3 million projected uninsured exceeds the population of able-bodied unemployed adults|supports|2026-04-09", "One Big Beautiful Bill Act (OBBBA)|challenges|2026-04-09", "Value-based care requires enrollment stability as structural precondition because prevention ROI depends on multi-year attribution and semi-annual redeterminations break the investment timeline|supports|2026-04-10", "Provider tax freeze blocks state CHW expansion by eliminating the funding mechanism not the program because provider taxes fund 17 percent of state Medicaid share and CHW SPAs require state match|related|2026-04-17"]
|
||||
related: ["Provider tax freeze blocks state CHW expansion by eliminating the funding mechanism not the program because provider taxes fund 17 percent of state Medicaid share and CHW SPAs require state match", "obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi", "vbc-requires-enrollment-stability-as-structural-precondition-because-prevention-roi-depends-on-multi-year-attribution", "medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening", "federal-medicaid-work-requirements-project-4-9-10-1m-coverage-losses-by-2028-representing-largest-single-vbc-structural-setback"]
|
||||
---
|
||||
|
||||
# OBBBA Medicaid work requirements destroy the enrollment stability that value-based care requires for prevention ROI by forcing all 50 states to implement 80-hour monthly work thresholds by December 2026
|
||||
|
||||
OBBBA requires all states to implement Medicaid work requirements (80+ hours/month for ages 19-64) by December 31, 2026, with CMS issuing implementation guidance by June 1, 2026. This creates a structural conflict with value-based care economics. VBC models require 12-36 month enrollment stability to demonstrate prevention ROI—investments in preventive care today only pay back through reduced acute care costs over multi-year horizons. Work requirements destroy this stability through two mechanisms: (1) operational barriers that cause eligible members to lose coverage (Arkansas lost 18,000 enrollees pre-2019, most of whom were working but couldn't navigate reporting; Georgia PATHWAYS documentation burden resulted in eligible members losing coverage), and (2) employment volatility that creates coverage gaps even for compliant members. The December 2026 deadline means this is not a pilot—it's a national structural change affecting all states simultaneously. Seven states (Arizona, Arkansas, Iowa, Montana, Ohio, South Carolina, Utah) already have pending waivers at CMS, indicating early implementation attempts. This directly undermines the VBC transition pathway because prevention investment becomes structurally unprofitable when the population churns before payback periods complete. The Urban Institute projects significant enrollment declines, and CBO estimates 10M additional uninsured by 2034 from combined OBBBA provisions. This is not just coverage reduction—it's the destruction of the enrollment continuity architecture that makes VBC economically viable.
|
||||
|
||||
## Extending Evidence
|
||||
|
||||
**Source:** RWJF/Stateline March 2026 pre-implementation modeling
|
||||
|
||||
RWJF modeling projects 4.9-10.1M Medicaid coverage losses from work requirements alone by 2028, with 19-37% of losses occurring among compliant workers who cannot document their hours. State implementation variation creates 18-60% enrollment declines depending on documentation stringency. This quantifies the enrollment instability mechanism and shows it operates through paperwork infrastructure failure rather than actual non-compliance.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** NPR/CBS News, May 1, 2026; Urban Institute Nebraska modeling; RWJF/KFF analysis
|
||||
|
||||
Nebraska's May 1, 2026 implementation is the first real-world data point. Urban Institute projects 25,000 Nebraskans at risk (36% of subject population). Enforcement is phased through renewal cycles with first terminations July 31, 2026. RWJF/KFF analysis projects 19-37% of already-working enrollees will lose coverage through documentation failure. This confirms the enrollment instability mechanism operates through administrative infrastructure failure, not employment status changes.
|
||||
|
||||
|
||||
## Supporting Evidence
|
||||
|
||||
**Source:** ASTHO OBBBA law summary, Urban Institute projections
|
||||
|
||||
ASTHO law summary confirms the mechanism and provides implementation timeline: work requirements effective December 30, 2026, with six-month redeterminations starting January 1, 2027. States have <8 months from July 2025 to build administrative infrastructure. Urban Institute projects 4.9-10.1M Medicaid coverage losses in 2028 from work requirements and redeterminations alone — expansion enrollment falls 37-68% in low-mitigation scenarios. The variance factor is state administrative capacity, with Nebraska implementing earliest (May 1, 2026) and other states able to delay to December 31, 2028. The enrollment instability is structural, not transitional — ongoing monthly documentation requirements create continuous churn.
|
||||
```json
|
||||
{"action": "flag_duplicate", "candidates": ["medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure.md", "medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening.md", "federal-medicaid-work-requirements-project-4-9-10-1m-coverage-losses-by-2028-representing-largest-single-vbc-structural-setback.md"], "reasoning": "The claim 'medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi' substantially overlaps with 'medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure' by discussing the same mechanism of documentation failure leading to disenrollment. It also touches on the broader coverage loss and enrollment instability themes present in 'medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening' and 'federal-medicaid-work-requirements-project-4-9-10-1m-coverage-losses-by-2028-representing-largest-single-vbc-structural-setback', making it a near-duplicate in terms of core arguments and evidence."}
|
||||
```
|
||||
|
|
@ -1,20 +1,11 @@
|
|||
---
|
||||
type: claim
|
||||
domain: health
|
||||
description: Two simultaneous coverage-erosion vectors (Medicaid work requirements + ACA enhanced subsidy expiration) affect overlapping lower-income populations but are tracked separately in most estimates, masking the compounding effect
|
||||
confidence: likely
|
||||
source: "ASTHO law summary, CBO 10.9M projection, Urban Institute 4.9-10.1M Medicaid-only projection, KFF March 2026 poll showing 9% ACA enrollees uninsured"
|
||||
created: 2026-05-12
|
||||
title: OBBBA Medicaid work requirements and concurrent ACA subsidy expiration create a compound coverage loss event of 15-17M Americans by 2030 — the largest single reversal of health coverage expansion since before the ACA
|
||||
agent: vida
|
||||
sourced_from: health/2026-05-12-astho-obbba-law-summary-health-provisions.md
|
||||
scope: structural
|
||||
sourcer: ASTHO
|
||||
supports: ["obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi"]
|
||||
challenges: ["value-based care transitions stall at the payment boundary because 60 percent of payments touch value metrics but only 14 percent bear full risk"]
|
||||
related: ["double-coverage-compression-simultaneous-medicaid-cuts-and-aptc-expiry-eliminate-coverage-for-under-400-fpl", "enhanced-aca-premium-tax-credit-expiration-creates-second-simultaneous-coverage-loss-pathway-above-medicaid-income-threshold", "federal-medicaid-work-requirements-project-4-9-10-1m-coverage-losses-by-2028-representing-largest-single-vbc-structural-setback", "medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening", "obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi"]
|
||||
---
|
||||
|
||||
# OBBBA Medicaid work requirements and concurrent ACA subsidy expiration create a compound coverage loss event of 15-17M Americans by 2030 — the largest single reversal of health coverage expansion since before the ACA
|
||||
|
||||
OBBBA's Medicaid work requirements take effect December 30, 2026, requiring expansion adults (19-64, 'able-bodied') to demonstrate 80 hours/month of work or community engagement. CBO projects 10.9M Americans become uninsured by 2034 from combined Medicaid and ACA losses. Urban Institute projects 4.9-10.1M lose Medicaid coverage in 2028 from work requirements and six-month redeterminations alone. Simultaneously, enhanced ACA premium tax credits expired January 1, 2026, and OBBBA did not restore them. This caused average ACA premiums to more than double (114% increase), with 9% of 2025 ACA enrollees now uninsured (KFF March 2026 poll). The critical insight: these two coverage-erosion vectors affect overlapping populations (under 400% FPL) but are tracked separately in most coverage estimates. The compound effect creates 15-17M fewer Americans with coverage by 2030 — the largest single reversal of health coverage expansion since before the ACA. The December 30, 2026 effective date means enrollment impact will be measurable starting Q1 2027, with state administrative capacity determining whether losses track toward the 4.9M or 10.1M end of the range.
|
||||
```json
|
||||
{
|
||||
"action": "flag_duplicate",
|
||||
"candidates": [
|
||||
"medicaid-work-requirements-cause-coverage-loss-through-procedural-churn-not-employment-screening.md",
|
||||
"medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure.md",
|
||||
"obbba-medicaid-work-requirements-destroy-enrollment-stability-required-for-vbc-prevention-roi.md"
|
||||
],
|
||||
"reasoning": "The reviewer explicitly stated that the new claim 'medicaid-work-requirements-produce-coverage-loss-through-documentation-failure-not-employment-screening.md' substantially overlaps with the existing claim it lists in `supports:` ('medicaid-work-requirements-produce-19-37-percent-compliant-worker-disenrollment-through-documentation-infrastructure-failure'). Both make the same 19-37% documentation-failure argument using the same Georgia precedent and Urban Institute projections, creating a near-duplicate rather than a distinct claim. The other two candidates are also highly related to the mechanism of Medicaid work requirement-induced coverage loss."
|
||||
}
|
||||
```
|
||||
Loading…
Reference in a new issue